Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy.
about
Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus.Strategies to improve outcomes for hepatitis C virus/human immunodeficiency virus coinfected liver transplant candidates.Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection
P2860
Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Treatment of severe recurrent ...... sing sofosbuvir-based therapy.
@en
type
label
Treatment of severe recurrent ...... sing sofosbuvir-based therapy.
@en
prefLabel
Treatment of severe recurrent ...... sing sofosbuvir-based therapy.
@en
P2093
P2860
P50
P356
P1476
Treatment of severe recurrent ...... sing sofosbuvir-based therapy.
@en
P2093
D M Brainard
J G McHutchison
K R Bhamidimarri
N A Terrault
P2860
P304
P356
10.1111/APT.13629
P407
P577
2016-04-21T00:00:00Z